Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hengchang Jieduyin is a Traditional Chinese Medicine (TCM) oral formulation developed by Shenzhen Riyuechang Technology for the management of opioid withdrawal syndrome. It is specifically indicated for alleviating the acute withdrawal symptoms and cravings associated with heroin addiction. The drug is composed of multiple herbal extracts that work synergistically to stabilize the central nervous system and restore homeostatic balance during detoxification. Clinical studies in China have evaluated its safety and efficacy compared to standard treatments like lofexidine or methadone tapering. The formulation typically aims to tonify Qi and blood while resolving toxins, a common therapeutic approach in TCM for addiction recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hengchang Jieduyin.